Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > generic

: 1P-LSD

or 2C-B

or Apixaban

Use the filters below to narrow your results.

None (1) · Eliquis (1) · Nexus, Eroxan (historical, late-1980s through mid-1990s) (1)

2C-x series (1) · Classic Psychedelic (1) · Lysergamide (1) · Phenethylamine (1) · Psychedelic (1) · Research material (1) · [[:Category:Anticoagulants|Anticoagulant]] (1) · [[:Category:Direct_factor_Xa_inhibitors|Direct factor Xa inhibitor]] (1) · [[:Category:DOACs|Direct oral anticoagulant (DOAC)]] (1)

5-HT2A partial agonist (1) · Prodrug of LSD; 5-HT2A agonist (1) · '"`UNIQ--vote-000001F6-QINU`"' CYP3A4 (primary) and P-glycoprotein substrate; strong dual inhibitors or inducers materially shift exposure. Reversal: andexanet alfa for life-threatening bleeding; 4F-PCC commonly used off-label when andexanet unavailable'"`UNIQ--ref-000001F7-QINU`"'. (1)

None (2) · '"`UNIQ--vote-000001F8-QINU`"', '"`UNIQ--vote-000001F9-QINU`"', '"`UNIQ--vote-000001FA-QINU`"' (1)

None (2) · NVAF: 5 mg PO BID (2.5 mg BID if 2 of 3: age ≥80, weight ≤60 kg, serum creatinine ≥1.5 mg/dL); acute VTE: 10 mg BID for 7 days, then 5 mg BID (1)

None (2) · 2.5 mg, 5 mg tablets (1)

None (2) · 10 mg BID for the first 7 days of acute VTE; otherwise 5 mg BID (1)

None (1) · insufflated (1) · Oral (2) · PR (1)

None (1) · 45-75 min (oral) (1) · Peak anticoagulant effect 3-4 hours (1)

None (1) · 12 hours (1) · 4-8 h (1)

None (1) · Not well characterized (1) · ~12 hours'"`UNIQ--ref-000001FB-QINU`"' (1)

None (1) · Not well characterized (1) · ~50% (oral; not significantly affected by food)'"`UNIQ--ref-000001FC-QINU`"' (1)

None (2) · Not established (1)

None (1) · [[USLegal:DEA Schedule I|Schedule I]] (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 3 results in range #1 to #3.

1

1P-LSD

2

2C-B

A

Apixaban

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"